The electron cooler of the CRYRING@ESR storage ring at the GSI-FAIR accelerator complex is a unique instrument, which not only provides beam cooling of the stored ions, but also serves as a low-energy electron target for Dielectronic Recombination experiments. The minimisation of vacuum contamination and the response to rapid energy changes are key requirements of the cooler in electron target mode. Therefore, a test bench was prepared to study the outgassing behaviour of the electron gun components and a setup was constructed to evaluate the drift-electrode-modulation of the acceleration voltage of the cooler. The vacuum studies showed that the electron gun cathode was severely malfunctioning and resulted in its replacement. The drift-electrode-modulation of the acceleration voltage showed significant improvements compared to direct modulation of the terminal voltage of the cooler.
13 May 2026 in The European Physical Journal Special Topics
We present developments at the electron cooler of the CRYRING@ESR storage ring aimed at improving its performance as internal target in low-energy electron–ion collision experiments. We describe recent modifications of the high-voltage and vacuum systems which lead to improved electron energy control and lower background count rates during such measurements. In a benchmark experiment on dielectronic recombination of F $$^\text {6+}$$ , we demonstrate that a spectroscopic resolution equivalent to transverse and longitudinal thermal electron energy spreads of $$\approx$$ 1 meV and $$\approx$$ 45 µeV, respectively, can be achieved under optimum conditions. This surpasses system performance observed previously in similar experiments.
Background/Objectives: Proton therapy has emerged as an advanced radiotherapy modality due to its unique physical dose distribution and its distinct radiobiological properties. The finite range of protons in tissue enables highly conformal dose delivery with minimal exit dose, significantly reducing irradiation of surrounding normal tissues compared to photon-based radiotherapy. Beyond these physical advantages, proton beams exhibit a spatially varying linear energy transfer that increases toward the distal edge of the spread-out Bragg peak, leading to clustered and complex DNA damage that is more difficult for cancer cells to repair. Methods: This review integrates experimental, computational, and clinical evidence to examine how proton-induced DNA damage, relative biological effectiveness, oxygen effects, and non-targeted responses contribute to tumor control and normal tissue sparing. Results: Comparative analyses with photon intensity-modulated radiotherapy demonstrate consistent reductions in acute and late toxicities across multiple tumor sites, particularly in pediatric patients and in tumors located near critical organs. The review also discusses emerging technologies, including pencil beam scanning, image-guided and adaptive proton therapy, compact accelerator systems, and ultra-high dose rate FLASH proton therapy, which collectively aim to enhance treatment precision, biological effectiveness, and accessibility. Conclusions: Together, these developments support proton therapy as a rapidly evolving modality with significant potential to improve therapeutic outcomes in modern oncology.